The Company That Makes Remdesivir Says it Considerably Reduces COVID-19 Deaths

In a report published Friday, researchers from biopharmaceutical company Gilead Sciences said that COVID-19 patients receiving its antiviral drug remdesivir experienced lower mortality rates and better recovery times compared to those not getting the treatment. The researchers compared 312 people hospitalized for COVID-19 and who received remdesivir to 818 people with similarly severe cases who … Read more